Skip to Main Content

Paper Details

Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.
NPJ Breast Cancer
6
2021
95-gene signature, BCa, ER, HER2, IHC4-mRNA, Male Breast Cancer, Male breast cancer, breast cancers, cancers, male breast cancer, male breast cancers, patients, transcriptomic gene risk signatures
Author NameAffiliation
Jane BayaniOntario Institute for Cancer Research
Jane BayaniUniversity of Toronto
Coralie Poncet
Cheryl CrozierOntario Institute for Cancer Research
Tammy PiperUniversity of Edinburgh
Carrie A CunninghamUniversity of Edinburgh
Monika S SobolUniversity of Edinburgh
Stefan AebiSwiss Group for Clinical Cancer Research (SAKK)
Kim BensteadCheltenham General Hospital
Oliver B??glerUniversity of Texas MD Anderson Cancer Center
Lissandra Dal LagoJules Bordet Institute
Judith FraserBeatson West of Scotland Cancer Centre
Florentine S Hilbers
Ingrid HedenfalkLund University
Larissa A KordeUniversity of Washington
Barbro LinderholmSahlgrenska University Hospital
John W M MartensErasmus Medical Center Rotterdam BOOG
Lavinia P MiddletonUniversity of Texas MD Anderson Cancer Center
Melissa P MurrayMemorial Sloan Kettering Cancer Center
Catherine M Kelly
Cecilia NilssonVastmanlands Hospital
Monika NowaczykSpecialist Hospital. St. Wojciech
Stephanie Peeters
Aleksandra Peric
Peggy L PorterFred Hutchinson Cancer Research Center & Department of Pathology, University of Washington
Carolien P Schr??derUniversity Medical Center Groningen BOOG
Isabel T RubioBreast Surgical Unit. Hospital Universitario Vall d'Hebron
Kathryn J RuddyMayo Clinic
Christi J van AsperenLeiden University Medical Center BOOG
Danielle Van den Weyngaert
Carolien H M van DeurzenErasmus Medical Center BOOG
A E van Leeuwen-Stok
Joanna Vermeij
Eric P WinerDana-Farber Cancer Institute
Sharon H GiordanoUniversity of Texas MD Anderson Cancer Center
Sharon H GiordanoUniversity of Texas MD Anderson Cancer Center
Fatima CardosoChampalimaud Clinical Center/Champalimaud Foundation EORTC
John M S BartlettOntario Institute for Cancer Research
John M S BartlettUniversity of Toronto
John M S BartlettUniversity of Edinburgh
  • 1 - 40

Datasets

Release 1.2